MelanieClaireDispenzaMDPhD
Allergy & Immunology • Baltimore, MDAssistant Professor at the Johns Hopkins University School of Medicine Division of Allergy and Clinical Immunology
Dr. Dispenza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5501 Hopkins Bayview Circle
Asthma and Allergy Center
Baltimore, MD 21224Phone+1 410-550-2300- Is this information wrong?
Summary
- Dr. Dispenza evaluates and treats adults at the Johns Hopkins Asthma & Allergy Center located on the Bayview campus. Her clinical interests include anaphylaxis, hives (urticaria), drug allergy, and food allergy. Her research focuses on IgE-mediated mechanisms of allergies and novel strategies for the diagnosis, prevention, and management of anaphylaxis.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Allergy and Immunology, 2015 - 2018- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2013 - 2015
Pennsylvania State University College of MedicineClass of 2013, MD, PhD
Certifications & Licensure
MD State Medical License 2019 - 2024
IL State Medical License 2016 - 2020- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Bruton's tyrosine kinase inhibition for the treatment of allergic disorders.Erica V Lin, Ragha V Suresh, Melanie C Dispenza> ;Annals of Allergy, Asthma & Immunology. 2024 Mar 14
- Examining cefazolin utilization and perioperative anaphylaxis in patients with and without a penicillin allergy label: A cross-sectional study.Murphy, Z., Massih, S., Klein, E., Fabre, V., Alvarez-Arango, S., Dispenza, M., Hensley, N., Blumenthal, K., Muzaffar, A.> ;Journal of Clinical Anesthesia. 2024 Jun 1
- Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trial.Ragha V Suresh, Collin Dunnam, Dhananjay Vaidya, Robert A Wood, Bruce S Bochner, Donald W MacGlashan Jr, Melanie C Dispenza> ;Research Square. 2023 Apr 5
- Join now to see all
Journal Articles
- Bruton’s Tyrosine Kinase Inhibition Effectively Protects Against Human IgE-Mediated AnaphylaxisMelanie Dispenza, MD, The Journal of Clinical Investigation
Books/Book Chapters
Authored Content
- Bruton’s Tyrosine Kinase Inhibition Effectively Protects Against Human IgE-Mediated AnaphylaxisJune 2020
Press Mentions
New Pill Could Prevent Anaphylaxis in People with Food, Drug AllergiesJune 2nd, 2020
Chemotherapy Drug Shows Promise in Treating Everyday AllergiesFebruary 20th, 2018- Pill That Treats Cancer Prevented Food Allergy Reactions in StudyOctober 24th, 2023
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
Johns Hopkins Bayview Medical CenterBaltimore, Maryland
Johns Hopkins HospitalBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
